BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30413605)

  • 1. Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma.
    Lian YF; Li SS; Huang YL; Wei H; Chen DM; Wang JL; Huang YH
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
    Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
    Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma.
    Meng X; Wang L; Zhu B; Zhang J; Guo S; Li Q; Zhang T; Zheng Z; Wu G; Zhao Y
    Biomed Res Int; 2020; 2020():8657468. PubMed ID: 32462022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the GINS complex, a key component of the eukaryotic replisome.
    MacNeill SA
    Biochem J; 2010 Jan; 425(3):489-500. PubMed ID: 20070258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
    Chen Y; Zhao J; Jiao Z; Wang W; Wang D; Yu X; Shi Z; Ge N; Pan Q; Xia J; Niu W; Zhao R; Zhang X; Du W
    BMC Cancer; 2018 Dec; 18(1):1240. PubMed ID: 30537941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognosis analysis of GINS subunits in human breast cancer.
    Li H; Cao Y; Ma J; Luo L; Ma B
    Medicine (Baltimore); 2021 Mar; 100(11):e24827. PubMed ID: 33725952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
    Yin F; Shu L; Liu X; Li T; Peng T; Nan Y; Li S; Zeng X; Qiu X
    J Exp Clin Cancer Res; 2016 Aug; 35(1):127. PubMed ID: 27567667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined analysis of expression, prognosis and immune infiltration of GINS family genes in human sarcoma.
    Zhang K; Zhou J; Wu T; Tian Q; Liu T; Wang W; Zhong H; Chen Z; Xiao X; Wu G
    Aging (Albany NY); 2022 Jul; 14(14):5895-5907. PubMed ID: 35896011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
    Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
    Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
    Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
    Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma.
    Zhou C; Chen Z; Xiao B; Xiang C; Li A; Zhao Z; Li H
    Front Cell Dev Biol; 2022; 10():951363. PubMed ID: 36092720
    [No Abstract]   [Full Text] [Related]  

  • 16. The Sulfolobus solfataricus GINS Complex Stimulates DNA Binding and Processive DNA Unwinding by Minichromosome Maintenance Helicase.
    Lang S; Huang L
    J Bacteriol; 2015 Nov; 197(21):3409-20. PubMed ID: 26283767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Acyl-CoA Ligase 4 (ACSL4) in Patients with Hepatocellular Carcinoma and its Prognosis.
    Sun XJ; Xu GL
    Med Sci Monit; 2017 Sep; 23():4343-4350. PubMed ID: 28887439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
    Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
    Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma.
    Yu DC; Chen XY; Li X; Zhou HY; Yu DQ; Yu XL; Hu YC; Zhang RH; Zhang XB; Zhang K; An JD
    Sci Rep; 2021 May; 11(1):11165. PubMed ID: 34045512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition.
    Chen DH; Wu QW; Li XD; Wang SJ; Zhang ZM
    Oncol Rep; 2017 Sep; 38(3):1533-1542. PubMed ID: 28731154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.